Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Specialized Medical CoSAU:4019 +0.50%17 5-Year Yield-on-Cost % is 2.00 as of Aug. 24, 2026, which is 1% below its 10-year median of 2.03. GuruFocus rates SAU:4019 with a GF Score™ of 17/100. The stock has 2 warning signs investors should review. Among 278 Healthcare Providers & Services companies, Specialized Medical Co ranks worse than 62.23% on this metric.
Specialized Medical Co's yield on cost for the quarter that ended in Jun. 2026 was 2.00.
The historical rank and industry rank for Specialized Medical Co's 5-Year Yield-on-Cost % or its related term are showing as below:
SAU:4019'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.92 Med: 2.03 Max: 2.26
Current: 2
During the past 2 years, Specialized Medical Co's highest Yield on Cost was 2.26. The lowest was 1.92. And the median was 2.03.
SAU:4019's 5-Year Yield-on-Cost % is ranked worse than 62.23% of 278
companies
in the Healthcare Providers & Services industry
Industry Median: 2.94
vs SAU:4019: 2.00
Specialized Medical Co (SAU:4019) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Specialized Medical Co 5-Year Yield-on-Cost % Related Terms
SAU:4019 vs HCA, THC, DVA: 5-Year Yield-on-Cost % Comparison
For the Medical Care Facilities subindustry, Specialized Medical Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Specialized Medical Co 5-Year Yield-on-Cost % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Specialized Medical Co's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Specialized Medical Co's 5-Year Yield-on-Cost % falls into.
Specialized Medical Co 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Specialized Medical Co (SAU:4019) has a 5-Year Yield-on-Cost % of 2.00 as of Aug. 24, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Specialized Medical Co and its competitors. This is near median its historical median of 2.03. Over the past decade, Specialized Medical Co's 5-Year Yield-on-Cost % has ranged from 1.92 to 2.26. According to the industry distribution chart, Specialized Medical Co ranks #173 out of 278 companies in the Healthcare Providers & Services industry, placing it in the top 62.2%.
Is Specialized Medical Co's 5-Year Yield-on-Cost % too high?
Specialized Medical Co's current 5-Year Yield-on-Cost % of 2.00 is near median its 10-year median of 2.03. Over the past 10 years, this metric has ranged from a low of 1.92 to a high of 2.26. The Healthcare Providers & Services industry median 5-Year Yield-on-Cost % is 2.94. Specialized Medical Co's value of 2.00 is 32% below this industry median. Based on the distribution chart, Specialized Medical Co ranks #173 out of 278 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Specialized Medical Co has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Specialized Medical Co's 5-Year Yield-on-Cost % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Specialized Medical Co ranks #173 out of 278 companies for 5-Year Yield-on-Cost %. This places Specialized Medical Co in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.94. Specialized Medical Co's value of 2.00 is 32% below this benchmark. Historically, Specialized Medical Co's own 5-Year Yield-on-Cost % has ranged from 1.92 to 2.26 over the past decade. While the company's 10-year median is 2.03 vs. the industry median of 2.94, Specialized Medical Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Healthcare Providers & Services company?
The median 5-Year Yield-on-Cost % among Healthcare Providers & Services companies is 2.94, based on 278 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Specialized Medical Co's current 5-Year Yield-on-Cost % of 2.00 is 32% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Specialized Medical Co and its competitors. For the Healthcare Providers & Services industry, the median 5-Year Yield-on-Cost % is 2.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Specialized Medical Co's current 5-Year Yield-on-Cost % is 2.00, which is near median its own 10-year median of 2.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Specialized Medical Co stock overvalued right now?
Specialized Medical Co (SAU:4019) has a current 5-Year Yield-on-Cost % of 2.00. The current 5-Year Yield-on-Cost % is 2.00, which is near median its 10-year median of 2.03 and 32% below the Healthcare Providers & Services industry median of 2.94. Specialized Medical Co's overall GF Score™ is 17/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Specialized Medical Co (SAU:4019), the current 5-Year Yield-on-Cost % is 2.00 as of Aug. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Specialized Medical Co is a full-service healthcare provider, offering a broad range of specialized medical services that encompass the entire healthcare value chain. The healthcare services provided by the company include ambulance services, cardiology, internal medicine, family medicine, and pediatrics. The company also offers surgical services, including general surgery, orthopedics, otorhinolaryngology, gynecological procedures, spinal surgery, obesity surgeries, and all general and specialized surgeries, supported by an integrated network of ancillary departments such as laboratories, diagnostic radiology, nuclear medicine services, anesthesia departments, internal pharmacies, physical therapy services, and nutritional consultations.
17GF Score
Get the complete analysis for SAU:4019
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:4019 has been successfully added to your 
